News from abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Jun 09, 2023, 10:55 ET Abbott Declares 398th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share. This marks the 398th consecutive...

Jun 01, 2023, 07:21 ET Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign

Jun 01, 2023, 07:19 ET Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign

- Abbott, Real Madrid and the Real Madrid Foundation launch 'Beat Malnutrition' campaign as part of a sustained collaboration urging communities to...

May 31, 2023, 09:00 ET Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign

Abbott, Real Madrid and the Real Madrid Foundation launch 'Beat Malnutrition' campaign as part of a sustained collaboration urging communities to...

May 24, 2023, 09:00 ET European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

New data presented from an investigator-sponsored European trial found managing indicated1 heart failure patients with Abbott's CardioMEMS™ HF System ...

May 20, 2023, 09:18 ET Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

Abbott (NYSE: ABT) today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a...

May 19, 2023, 09:00 ET Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's TactiFlex™ Ablation Catheter, Sensor...

May 18, 2023, 09:00 ET Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term

Abbott (NYSE: ABT) today announced its Assert-IQ™ insertable cardiac monitor (ICM) has received U.S. Food and Drug Administration (FDA) clearance,...

May 16, 2023, 09:00 ET Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options

FDA approval was backed by Abbott's DISTINCT study, the largest randomized controlled trial for spinal cord stimulation (SCS) in people with chronic...

May 11, 2023, 09:00 ET Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative

Abbott (NYSE: ABT) today announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and...

Apr 27, 2023, 16:10 ET Abbott Completes Acquisition of Cardiovascular Systems, Inc.

Abbott (NYSE: ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an...

Apr 25, 2023, 09:00 ET Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients

Abbott (NYSE: ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life...

Apr 20, 2023, 09:00 ET Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change

Abbott is joining the Climate Amplified Disease and Epidemics (CLIMADE) consortium, which will use data science to predict, track and control...

Apr 19, 2023, 07:15 ET Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023. First-quarter GAAP diluted EPS of $0.75 and adjusted ...

Apr 17, 2023, 08:00 ET Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries

The Medicare program has expanded access to continuous glucose monitoring systems like the FreeStyle Libre 2 system and the FreeStyle Libre 14 day...

Apr 14, 2023, 09:00 ET FDA Clears Reader for Abbott's FreeStyle Libre® 3 System

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has cleared a reader for its FreeStyle Libre® 3 integrated...

Mar 29, 2023, 09:00 ET Abbott Hosts Conference Call for First-Quarter Earnings

Abbott will announce its first-quarter 2023 financial results on Wednesday, April 19, 2023, before the market opens. The announcement will be...

Mar 28, 2023, 09:00 ET Abbott recebe aprovação da ANVISA para Navitor, uma nova geração do sistema TAVI para tratar estenose aórtica

Mar 23, 2023, 09:00 ET Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement

The Concussion Awareness Now campaign raises awareness both about the common, everyday ways concussions most often happen and the importance of...

Mar 14, 2023, 09:00 ET A Abbott lança o autoteste Panbio HIV para oferecer mais rapidez, confiança e a discrição de um teste feito em casa

Mar 07, 2023, 09:00 ET Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion

Abbott (NYSE: ABT) has received U.S. Food and Drug Administration clearance for what will be the first commercially available laboratory traumatic...

Mar 06, 2023, 07:00 ET U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 2 and FreeStyle Libre 3...

Mar 05, 2023, 09:07 ET Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device

New five-year data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal...

Mar 04, 2023, 10:41 ET New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation

Abbott (NYSE: ABT) today announced late-breaking data for the TriClip™ transcatheter edge-to-edge repair (TEER) system, a first-of-its-kind minimally ...